NEITHER THIS WARRANT NOR THE SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE...Weikang Bio-Technology Group Co., Inc. • December 8th, 2010 • Medicinal chemicals & botanical products
This Warrant is being issued pursuant to an engagement letter, dated September 30, 2010, by and between the Company and the Initial Holder (the “Engagement Letter”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 8th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products
This Agreement is made pursuant to separate Subscription Agreements, dated as of the date hereof, between the Company and each Purchaser (the “Subscription Agreements”).
SETTLEMENT AGREEMENT AND RELEASESettlement Agreement and Release • August 10th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products • California
This Settlement Agreement and Release (“Agreement”) is entered into this 6th day of August, 2010 (the “Effective Date”) by and among Sinary Bio-Technology Holdings Group, Inc. (“Sinary”) on the one hand, and Yin Wang and Wei Wang (together with Yin Wang, the “Sellers”), on the other hand. Sinary and the Sellers will be referred to collectively in this Agreement as the “Parties.”
ASSIGNMENT OF RIGHTS AGREEMENTAssignment of Rights Agreement • August 9th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products
This Assignment of Rights Agreement is entered into as of this 29th day of June 2010, by and among Weikang Bio-Technology Group Co., Inc., a Nevada corporation (the “Company”), Weili Wang (the “Assignor”) and Lucky Wheel Limited, a British Virgin Islands corporation (the “Assignee”) incorporated on January 6, 2010, upon the following premises:
LOCK-UP AGREEMENTLock-Up Agreement • December 8th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products • California
THIS AGREEMENT (this “Agreement”) is dated as of December 2, 2010 by and between Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the “Company”), and ____________ (“Shareholder”).
SHELL COMPANY PURCHASE AGREEMENTShell Company Purchase Agreement • March 25th, 2010 • Weikang Bio-Technology Group Co., Inc.
THIS SHELL COMPANY PURCHASE AGREEMENT (this “Agreement”), is dated as of Dec.8, 2007, by and between Sinary Bio-Technology Holdings Group, Inc. (Party A) and Wangyin,CEO of Weikang (Party B)
AMENDMENT TO MAKE GOOD SECURITIES ESCROW AGREEMENTMake Good Securities Escrow Agreement • December 29th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products • New York
THIS AMENDMENT dated as of December 22, 2010 (“Amendment”), is by and among Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the “Company”), Lucky Wheel Limited (the “Principal Shareholder”), a British Virgin Islands corporation, and Sichenzia Ross Friedman Ference LLP with an address at 61 Broadway, 32nd Floor, New York, NY 10006 (the “Escrow Agent”).
JOINT FILING AGREEMENTJoint Filing Agreement • August 9th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the common stock of Buddha Steel, Inc., and that this Agreement be included as an Exhibit to such joint filing.
Purchase AgreementPurchase Agreement • March 30th, 2012 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products
INVESTOR AND PUBLIC RELATIONS ESCROW AGREEMENTInvestor and Public Relations Escrow Agreement • December 8th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products • New York
This Agreement, dated as of December 2, 2010 (this “Agreement”), is entered into by and among Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the “Company”), Sichenzia Ross Friedman Ference LLP (the “Escrow Agent”), and MidSouth Investor Fund LP, as representative for the Subscribers in that certain Subscription Agreement (as defined herein) (“Subscriber Representative) (the Company and the Subscriber Representative are collectively referred to as “Escrowing Parties”).
Lease agreementLease Agreement • March 25th, 2010 • Weikang Bio-Technology Group Co., Inc.
This agreement is entered into this day of January 1, 2008, by and between Heilongjiang Weikang Bio-technology Group Company Inc. (“Party A”) and Harbin Dongfeng Pharmaceutical Corp., ltd (“Party B”).
MAKE GOOD SECURITIES ESCROW AGREEMENTMake Good Securities Escrow Agreement • December 8th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products • New York
THIS MAKE GOOD SECURITIES ESCROW AGREEMENT (the “Make Good Agreement” or the “Agreement”), dated as of December 2, 2010, is entered into by and among Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the “Company”), Lucky Wheel Limited (the “Principal Shareholder”) and Sichenzia Ross Friedman Ference LLP with an address at 61 Broadway, 32nd Floor, New York, NY 10006 (the “Escrow Agent”).
CALL OPTION AGREEMENT BETWEEN WANG, WEI LI AND Individual Listed in Schedule A 附件A所列个人 Date: May 5, 2010Call Option Agreement • August 10th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products • Virgin Islands
THIS CALL OPTION AGREEMENT (this "Agreement") is made on May 5, 2010 by and between WANG, WEI LI, a US passport holder, (the "Grantor"), and the individual listed in Schedule A (the "Grantee").
ASSIGNMENT OF RIGHTS AGREEMENTAssignment of Rights Agreement • August 9th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products
This Assignment of Rights Agreement is entered into as of this 29th day of June 2010, by and among Weikang Bio-Technology Group Co., Inc., a Nevada corporation (the “Company”), Weili Wang (the “Assignor”) and Lucky Wheel Limited, a British Virgin Islands corporation (the “Assignee”) incorporated on January 6, 2010, upon the following premises:
ESCROW DEPOSIT AGREEMENTEscrow Deposit Agreement • December 8th, 2010 • Weikang Bio-Technology Group Co., Inc. • Medicinal chemicals & botanical products • New York
This ESCROW DEPOSIT AGREEMENT (this “Agreement”) dated as of this 25th day of October, 2010, by and among Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the “Company”), having an address at No. 365 Chengde Street, Daowai District, Harbin Heilongjiang Province, The People’s Republic of China 150020, Hunter Wise Securities, LLC, a California limited liability company (“Placement Agent”), having an address at 2361 Campus Drive, Suite 100, Irvine, CA 92612, and SIGNATURE BANK (the “Escrow Agent”), a New York State chartered bank, having an office at 950 Third Avenue, 9th Floor, New York, NY 10022. All capitalized terms not herein defined shall have the meaning ascribed to them in that certain Confidential Private Placement Memorandum, dated October 25. 2010 as amended or supplemented from time-to-time, including all attachments, schedules and exhibits thereto (the “Memorandum”).
